US-Brazil Research Collaboration on Strain Variation in TB
美国-巴西关于结核病菌株变异的研究合作
基本信息
- 批准号:7491530
- 负责人:
- 金额:$ 48.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-01 至 2010-04-30
- 项目状态:已结题
- 来源:
- 关键词:Acid Fast Bacillae Staining MethodAddressAffectAnimal ExperimentsAntigenic VariationArtsBacillus (bacterium)BehaviorBiologyBrazilCalmette-Guerin BacillusCell physiologyCharacteristicsCitiesClassificationClinicalClinical ResearchClinical SciencesClinical TrialsCollaborationsCountryDiseaseDisease OutbreaksDisease ProgressionElementsEnrollmentEnvironmental Risk FactorEpidemicEpidemiologic StudiesEpidemiologistEventExposure toFamilyFutureGenesGeneticGenetic PolymorphismGenomeGenomicsGoalsGrowthHealthHouseholdHumanImmuneImmune responseImmune systemImmunityImmunogeneticsImmunologistImmunologyInfectionInternationalInterventionKineticsLaboratoriesLiteratureMolecularMultidrug-Resistant TuberculosisMycobacterium InfectionsMycobacterium tuberculosisNatural ImmunityNewly DiagnosedNumbersOnline SystemsOrganismPatientsPhasePhenotypePopulationPrevalencePreventionProteomePublic HealthPulmonary TuberculosisQualifyingQuality ControlRateRecurrenceReportingResearchResearch DesignResearch InfrastructureResearch PersonnelResearch TrainingResistanceRiskSingle Nucleotide PolymorphismSiteSocial MedicineSpottingsStandards of Weights and MeasuresTestingThinkingTimeTraining and InfrastructureTreesTuberculosisUniversitiesVaccinationVaccinesVariantWorld Health Organizationbasecell growthcombinatorialcytokinedesigndisease transmissionfollow-upinnovationinsightmacrophagenovelprogramsresearch studytraittransmission processurban area
项目摘要
DESCRIPTION (provided by applicant): Tuberculosis (TB) is a major public health concern in Brazil. This ICIDR proposal builds on a pre-existing collaboration between Drs. Ellner, Dietze, Rodrigues and Palaci and will enhance the scientific infrastructure and training capabilities of the Nucleo de Doengas Infecciosas (NDI) in Vitoria Brazil and provide information essential to address the TB problem. Our hypothesis is that strain variation in Mycobacterium tuberculosis (MTB) is a determinant of the extent of transmission of infection in household contacts with pulmonary TB, the risk of progressing from infection to disease, and the protection conferred by prior mycobacterial infection/vaccination. Our group has discovered a set of synonymous single nucleotide polymorphism (SNP) markers in MTB and used them to construct an unequivocal evolutionary tree of the species making it possible to precisely determine how different clinical strains are related, and to identify strain families likely to share phenotypic traits. We also have discovered new mechanisms for genomic diversity among clinical MTB strains. Overall, these discoveries have uncovered a hitherto unsuspected degree of polymorphism in MTB that may allow it to adapt to host immune responses by antigenic variation and changes in its other cellular functions. A novel household contact design conducted in Vitoria, Brazil will be used to accomplish the following: Aim 1. To determine whether some clinical strains are more transmissible or cause more disease progression in infected patients, whereas other strains have the opposite phenotype, and to determine whether strains with different phenotypes diverge in the way they interact with the host immune system. Aim 2. To determine if strains vary in the way that they interact with the innate immune system and the degree to which host differences influence this interaction. Aim 3. To determine the degree to which adaptive immunity to MTB is strain-specific, and to discover the principal strains or bacterial factors that could be combined in a future vaccine effective against all MTB strains. This program creates a collaboration among leading epidemiologists, immunologists, molecular biologists and microbiologists from the U.S. and Brazil that will enable cutting edge research and training on crucial aspects of tuberculosis biology and immunology in human populations using an innovative epidemiological study design.
描述(由申请人提供):结核病(TB)是巴西的一个主要公共卫生问题。该ICIDR提案建立在Ellner、Dietze、Rodrigues和Palaci博士之间的现有合作基础上,将加强维托里亚巴西国家结核病研究所(NDI)的科学基础设施和培训能力,并提供解决结核病问题所必需的信息。我们的假设是,结核分枝杆菌(MTB)的菌株变异是家庭接触者肺结核感染传播程度、从感染进展为疾病的风险以及既往分枝杆菌感染/疫苗接种所提供保护的决定因素。我们的研究小组在结核分枝杆菌中发现了一组同义单核苷酸多态性(SNP)标记,并使用它们构建了该物种的明确进化树,从而可以精确确定不同临床菌株之间的相关性,并确定可能共享表型性状的菌株家族。我们还发现了临床MTB菌株之间基因组多样性的新机制。总体而言,这些发现揭示了MTB中迄今未被怀疑的多态性程度,这可能允许其通过抗原变异和其其他细胞功能的变化来适应宿主免疫应答。在巴西维托里亚进行的一项新颖的家庭接触设计将用于实现以下目标:目标1。确定某些临床菌株是否更具传播性或在感染患者中导致更多疾病进展,而其他菌株具有相反的表型,并确定具有不同表型的菌株是否在与宿主免疫系统相互作用的方式上存在差异。目标2.确定菌株与先天免疫系统相互作用的方式是否不同,以及宿主差异影响这种相互作用的程度。目标3.确定对MTB的适应性免疫是菌株特异性的程度,并发现可以在未来有效对抗所有MTB菌株的疫苗中组合的主要菌株或细菌因子。该计划在来自美国和巴西的领先流行病学家,免疫学家,分子生物学家和微生物学家之间建立了合作,这将使用创新的流行病学研究设计,对人类结核病生物学和免疫学的关键方面进行前沿研究和培训。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jerrold J. Ellner其他文献
Dynamic of infectious aerosols generated by cough from patients with pulmonary tuberculosis
肺结核患者咳嗽产生的感染性气溶胶的动态变化
- DOI:
10.1016/j.jaerosci.2025.106633 - 发表时间:
2025-09-01 - 期刊:
- 影响因子:2.900
- 作者:
Taline Canto Tristão;Mariana Abou Mourad Ferreira;Pedro Sousa de Almeida Júnior;Luiz Guilherme Schmidt Castellani;Manuela Negrelli Brunetti;Edward C. Jones-López;Kevin P. Fennelly;Michael R. Barer;Carlos Henrique Fantecelle;Saulo Almeida Morellato;David Jamil Hadad;Jerrold J. Ellner;Reynaldo Dietze;Moisés Palaci - 通讯作者:
Moisés Palaci
Predictors of Loss to Follow-Up among Men with Tuberculosis in Puducherry and Tamil Nadu, India
印度本地治里和泰米尔纳德邦男性结核病患者随访失败的预测因素
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:3.3
- 作者:
Thomas J. Zhou;S. Lakshminarayanan;S. Sarkar;S. Knudsen;C. Horsburgh;M. Muthaiah;Carolyn K. Kan;P. Salgame;Jerrold J. Ellner;G. Roy;Helen E. Jenkins;Natasha S. Hochberg - 通讯作者:
Natasha S. Hochberg
Diverse interactions of Mycobacterium tuberculosis infection and of BCG vaccination with SARS-CoV-2
结核分枝杆菌感染和卡介苗疫苗接种与 SARS-CoV-2 的多种相互作用
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
P. Salgame;S. Pentakota;J. C. M. Malabad;P. Narasimhan;Sheetal Verma;S. Prakash Babu;Vartika Sharma;Sonali Sarkar;Marissa M. Alejandría;Jerrold J. Ellner - 通讯作者:
Jerrold J. Ellner
Invasive primary cutaneous phycomycosis in diabetic leg ulcers.
糖尿病腿部溃疡的侵袭性原发性皮肤藻真菌病。
- DOI:
10.1001/archsurg.1980.01380060068020 - 发表时间:
1980 - 期刊:
- 影响因子:0
- 作者:
J. W. Tomford;Diana Whittlesey;Jerrold J. Ellner;Joseph F. Tomashefski - 通讯作者:
Joseph F. Tomashefski
Two cases of rhinocerebral zygomycosis (mucormycosis) with common epidemiologic and environmental features.
两例具有共同流行病学和环境特征的鼻脑接合菌病(毛霉菌病)。
- DOI:
- 发表时间:
1981 - 期刊:
- 影响因子:0
- 作者:
Albert C. England;Mark Weinstein;Jerrold J. Ellner;Libero Ajello - 通讯作者:
Libero Ajello
Jerrold J. Ellner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jerrold J. Ellner', 18)}}的其他基金
Bacterial and host determinants of progression, manifestations and consequences of TB
结核病进展、表现和后果的细菌和宿主决定因素
- 批准号:
10271648 - 财政年份:2021
- 资助金额:
$ 48.21万 - 项目类别:
Bacterial and host determinants of progression, manifestations and consequences of TB
结核病进展、表现和后果的细菌和宿主决定因素
- 批准号:
10493271 - 财政年份:2021
- 资助金额:
$ 48.21万 - 项目类别:
Training of Ugandans in Basic Research on TB and Emerging Infectious Diseases
对乌干达人进行结核病和新发传染病基础研究培训
- 批准号:
8664524 - 财政年份:2014
- 资助金额:
$ 48.21万 - 项目类别:
Training of Ugandans in Basic and Translational Research on TB and Emerging Infectious Diseases
对乌干达人进行结核病和新发传染病基础和转化研究培训
- 批准号:
9751525 - 财政年份:2014
- 资助金额:
$ 48.21万 - 项目类别:
Training of Ugandans in Basic and Translational Research on TB and Emerging Infectious Diseases
对乌干达人进行结核病和新发传染病基础和转化研究培训
- 批准号:
10206668 - 财政年份:2014
- 资助金额:
$ 48.21万 - 项目类别:
Training of Ugandans in Basic and Translational Research on TB and Emerging Infectious Diseases
对乌干达人进行结核病和新发传染病基础和转化研究培训
- 批准号:
10341224 - 财政年份:2014
- 资助金额:
$ 48.21万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 48.21万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 48.21万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 48.21万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 48.21万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 48.21万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 48.21万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 48.21万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 48.21万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 48.21万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 48.21万 - 项目类别:
Research Grant